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Abstract 
Dedicator of cytokinesis (DOCK) is a family of 
proteins with 11 members in mammal which can 
regulate cell motility, phagocytosis, myoblast fusion, 
tumor suppression, neuronal polarization and 
adhesion. They are classified into four subfamilies A 
to D. Dock1 (Dock180), the founding member of the 
family, is a large protein which includes an N-
terminal SH3 domain and a flanking helical bundle 
that are vital to the formation of a functioning 
complex Dock1-ELMO1 (Gumienny et al.,2001; 
Grimsley et al.,2004; Komander et al., 2008). 
Genetic and biochemical studies show that DOCK1 
acts as a guanine-nucleotide exchange factor (GEF) 
for the small GTPase Rac1 (Diyokawa et al., 1998; 
Nolan et al., 1998). Rac1 is a small GTPase required 
for myoblast fusion in organisms such as fruit flies, 
zebrafish and mice (Rochlin et al., 1998). In addition 
to playing an important role in a broad spectrum of 
biological processes, numerous studies have 
demonstrated contributions of DOCK members to 
the development of cancer. Deciphering the detailed 
mechanisms by which DOCK proteins participate in 
tumorigenesis will shed light on the design of new 
treatment strategies. 
Keywords 
DOCK1 
Identity 
Other names: ced5, DOCK 180 
HGNC (Hugo): DOCK1 
Location: 10q26.13-q26.3 
DNA/RNA 
Description 
The DOCK1 gene is 6797 base pairs in length 
encoding a large protein (about 180kDa). 
Transcription 
Variant (1) represents the longer transcript and 
encodes the longer isoform (1).  
Variant (2) uses an alternate splice site at an internal 
exon, compared to variant 1.  
The encoded isoform (2) is shorter, compared to 
isoform 1. 
Protein 
Description 
Dock1 is a 180 kDa protein and largely responsible 
for regulating Rac-mediated polarization, migration, 
phagocytosis of apoptotic cells, myoblasts fusion 
and macrophages in vitro (Cte etal., 2005; Grimsley 
etal., 2004; Pajcini et al., 2008) DOCK1 and its 
homologues in Drosophila (Myoblast city) and 
C.elegans (CED-5) represent an evolutionarily 
conserved family of proteins which is called CDM 
(CED-5, DOCK180, MBC)-family (Wu and 
Horvitz, 1998).  
DOCK1 has 6 splice variants with two protein-
coding transcripts generating products consisting of 
1865 and 1886 amino acids respectively.  
The others are non-protein-coding transcripts.  
An SH3 domain at the A- terminus and two domain 
CRK-binding sequences at the carboxyl end have 
been identified in Dock1 (Hideki Hasegawa et al, 
1996). 
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There are two high sequence homology named 
DHR-1 and DHR-2 among Dock family members 
(Jean Francois Cote and Kristiina Vuori, 2002). 
DHR1 domain is 200-250 amino acids long that 
binds phospholipids, whereas DHR2 domain of 450-
550 amino acids is responsible for the guanine 
nucleotide exchange activity (25022758). 
Expression 
DOCK1 is predominantly located in the cytoplasm 
of cells. Nuclear localization of DOCK1 has also 
been reported (Zhao et al., 2011). 
Function 
This family is one of the GEFs being identified as 
activators of Rho GTPases (Takai etal., 1996; 
Hasegawa et al., 1996; Erickson and Cerione, 2004). 
DOCK1 activates Rho GTPase through facilitating 
the exchange of bound GDP for GTP. GTPases can 
regulate actin cytoskeleton and be accountable for 
crucial biological functions, such as cell 
phagocytosis, cell migration, cell proliferation, cell 
survival, cell polarity, axonal guidance, transcription 
and intracellular trafficking (Iwasato et al., 2007; 
Schmidt and Hall, 2002). In addition to playing an 
important role in a broad spectrum of biological 
processes, numerous studies have demonstrated 
contribution of DOCK members to the development 
of cancer. 
Description 
DHR domain  DOCK1 and its homologues in 
Drosophila (Myoblast city) and C.elegans (CED-5) 
represent an evolutionarily conserved family of 
proteins which is called CDM (CED-5, DOCK180, 
MBC)-family(Wu and Horvitz, 1998). This family is 
one of the GEFs being identified as activators of Rho 
GTPases (Takai etal., 1996; Hasegawa et al., 1996; 
Erickson and Cerione, 2004). The other family is 
Db1 family (Hart et al., 1991) and all their members 
contain the Db1 Homology (DH) and the Pleckstrin 
Homology (PH) domains (Klinger et al., 2004; 
Srivastava et al., 1986; Worthylake te al., 2004; Feng 
et al.,2002; Baird et al., 2005). While DH domains 
directly catalyze GDP-GTP exchange, PH domains 
target proteins to membranes and mediate protein-
protein interactions. DOCK 180-related proteins can 
catalyze nucleotide exchange without homology to 
DH/PH domains, which are characterized by two 
protein domains named DOCK homology regions 1 
and 2 (DHR-1 and DHR-2, respectively) (Brugnera 
et al., 2002; Cote and Vuori, 2002). DOCK1 contains 
1864 amino acids, a Src-homology 3 (SH3) domain 
at the amino terminus, a few proline-rich motifs at 
the carboxyl terminus and a potential 
phosphatidylinositol trisphosphate (PtdInsP3)-
interacting motif near its C terminus (Hasegawa et 
al.m 1996; Kobayashi et al 2001). Inactivation of the 
DHR-2 (also known as CZH2 or DOCKER) in 
DOCK1 can inhibit Rac activation, cell migration 
and clearance of apoptotic cells. This demonstrates 
the necessity and sufficiency of DHR-2 to promote 
GDP/GTP exchange on various GTPases. DHR-2 
has been suggested to consist of about 500 residues 
(Brugnera et al., 2002; Cote and Vuori, 2002). DHR-
2 domains of these family members have been 
shown to interact with the nucleotide-free form of 
Rho GTPase leading to the exchange of GDP for 
GTP(Meller et al., 2004; Lin et al., 2006; Miyamoto 
et al., 2006; Nishikimi et al 2005). DHR-1 domain 
(also known as CZH1) is located upstream of DHR-
2 domain (Meller et al., 2002) and is a novel PtdIns 
(3,4,5)P3-binding module which directly interacts 
with phosphoinositides (PI),playing an important 
role in Rac-mediated cell polarity and migration 
including myoblast fusion(Cote and Vuori, 2002). 
SH3 domains src-homology3 (SH3) domains are 
protein-protein interaction modules in intracellular 
signal transduction. DOCK1 contains an SH3 
domain at its N-terminus. SH3 domains have been 
reported to bind to a proline-finch motif at the C-
terminus of ELMO (gumienny et al., 2001) which 
will be regulating the activation status of DOCK1. In 
DOCK1, SH3 domain interacts with DHR-2 domain 
directly which is dependent on a proline-rich region 
in DHR-2 domain, but inhibits some functions of the 
DHR-2 domain, such as binding to nucleotide-free 
Rac and facilitating GTP loading(Lu et al., 2005). 
Interaction with ELMO ELMO is an evolutionarily 
conserved upstream regulator of Rac that takes effect 
at the same step as DOCK 1 in phagocytosis of 
apoptotic cells and cell migration (Gumienny et al., 
2001). DOCK2-5 and DOCK 1 have an amino-
terminal Src homology (SH)-3 domain which can 
interact with ELMO proteins and cooperate to 
activate Rac (Grimsley et al., 2004; Hiramoto et al., 
2006). Other Dock-related proteins such as DOCK 
6-8 and DOCK9-11 cannot physically interact with 
ELMO proteins due to the lack of a recognizable 
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SH3 domain. Some studies showed that deletion 
mutants of DOCK 180 that fail to bind to ELMO 
could not efficiently activate Rac even when over-
expressed in cells (Grimsley et al., 2004). Other 
studies suggested that owing to auto-inhibition, the 
isolated DHR-2 appears to have much higher GEF 
activity than total DOCK 180 (Lu et al., 2005; Cote 
et al., 2007). Co-expression of ELMO is required to 
relieve the auto-inhibited state (Lu et al., 2004; Santy 
et al., 2005). The ELMO-DOCK1 complex is located 
in the cytoplasm and will be translocated to the cell 
membrane, which is the key step for DOCK1 to 
activate Rac (Debakker et al., 2004; Katoh and 
Negishi et al., 2003; Hasegawa et al., 1996; Katoh et 
al., 2006). All three mammalian ELMO 1-3 proteins 
have no obvious catalytic activity. They have three 
recognizable features including armadillo repeats at 
the N-terminus, an atypical PH domain and a 
complex prolin-rich region at the C-terminus. In fact, 
the functions of ELMO proteins in mediating Rac 
signaling remain largely unknown, and the 
interaction between ELMO and DOCK is still 
unclear. Some data indicate that there are two contact 
regions between DOCK1 and ELMO1. The atypical 
ELMO1 PH domain and an uncharacterized region 
between the SH3 and DHR-1 domains primarily 
interact with each other. This interaction is sufficient 
to promote complex formation. N-terminal SH3 
domain of DOCK1 and the C-terminal PxxP motifs 
of ELMO1 are involved in the second contact 
(Komander et al., 2008). The PH domain and 
proline-rich motifs are implicated in binding to 
DOCK protein (Manishha et al., 2011). It has been 
documented that the SH3 domain of DOCK1 binds 
to a proline-rich (pro-rich) motif at the C-terminus of 
ELMO, and this in turn would activate DOCK 1. 
This is the second interaction. So when either of 
these motifs is mutated, the interaction of ELMO and 
DOCK1 is completely interrupted (Gumienny et al., 
2011; Lu et al., 2005). The PH domain of ELMO 
stabilizes the DOCK1-nucleotide-free Rac complex 
through binding "in trans" instead of interacting 
directly with either Rac or DOCK 180 (Lu et al, 
2004). The atypical PH domain of ELMO plays a 
crucial role in increasing the catalytic activity of 
DOCK 180 towards Rac. ELMO1 or ELMO2, could 
coexpress with DOCK1, and overexpression of 
ELMO1 together with DOCK1 synergistically 
enhances phagocytosis(Zhou et al., 2001). ELMO 
PH domain could slightly enhance the catalytic 
activity of DOCK 1 toward Rac by about twofold in 
vitro. But this effect could be efficient in vivo 
because the Ced-12 PH domain mutations let Ced-
12-null worms failed to rescue the migration defects 
(Lu et al., 2004). Therefore, the mechanism of action 
of Elmo remains inconclusive. Further studies are 
required to clarify the controversies. 
Binding to Crk  Crk is an adaptor protein consisting 
mostly of SH2 and SH3 domains which is also 
involved in signaling processes, such as cell 
adhesions, differentiation, migration, proliferation, 
and phagocytosis of apoptotic cells (Clark and 
Brugge, 1995; Juliano and Haskill, 1993; Richardson 
and Parsons, 1995).  
Crk gene can be translated into two proteins, Crk-I 
and Crk-II which are primarily isolated as oncogenic 
products (Mayer etal., 1988; Matsuda et al., 1992). 
DOCK180/DOCK1 can bind with the SH3 of the 
Crk through PxxP region in its C-termini (Matsuda 
et al., 1996). It has been shown that DOCK 1 has two 
C-terminal CRK-binding sequences. DOCK1 binds 
with Crk on the basis of a biochemical interaction. 
The complex will be transiently translocated to the 
membrane resulting in changes in cell morphology 
(Hasegawa et al., 1996). 
Essential for myoblast fusion Mammalian 
myogenesis arises from the fusion of mononucleated 
myoblasts. Myogenic cells fuse with each other to 
form multinucleated myotubes (Horsley and Pavlath, 
2004). Myoblast fusion is responsible for 
development during embryogenesis and postnatal 
maintenance, growth, and helps regenerate injured 
tissue (Cerletti et al.m 2008; Rudnicki et al., 2008).  
Proper regulation of myoblast fusion events 
determines myofiber length, appropriate contractile 
capacity and muscle function(Allen et al., 1999). In 
fact, the understanding of myoblast fusion of higher 
vertebrates remains poor. Current knowledge is 
largely derived from genetic analyses performed in 
Drosophila(Chen and Olson, 2004; Taylor, 2003) 
and in vivo experiments in vertebrates (Cote and 
Vuori, 2007).  
In Drosophila melanogaster, fusion-competent 
myoblasts and founder cells regulate the formation 
of multinucleate muscle fibers. At cellular level, the 
processes of myoblast fusion include alignment, 
actin cytoskeleton rearrangement at the contact sites 
and membrane fusion (Knudsen and Horwitz, 1977; 
Wakelam, 1985; Peckham, 2008; Duan and 
Gallagher, 2009). CDM superfamily consists of 
founding members such as MBC, human DOCK1, 
Caenorhabditis elegans CED-5 (Wu and Horvitz, 
1998) and almost 20 additional members (Cote and 
Vuori, 2002). Myoblast city (mbc) is highly 
important in Drosophila melanogaster embryo for 
multinucleate fibers formation.  
It has been reported that Mbc together with ELMO, 
function as an atypical bipartite GEF to directly 
control Rac1 in vivo. Drosophila eye experiments 
show that Mbc and ELMO interaction will increase 
the activity of Ras (Gersbrecht et al., 2008). 
Homology 
In mammals, dedicator of cytokinesis (DOCK) 
represents a new family of proteins comprising 11 
members named DOCK1 (also known as Dock180) 
to Dock11. They are classified into four subfamilies 
denoted Dock-A, -B, -C, -D. 11 members are 
DOCK1 (Dedicator of cytokinesis 1) Li P, et al. 
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classified as following: DOCK-A subfamily 
(DOCK1, DOCK2 and DOCK5); DOCK-B 
subfamily (DOCK3 and DOCK4); DOCK-C 
subfamily (DOCK6, DOCK7 and DOCK8); DOCK-
D subfamily (DOCK9, DOCK10 and DOCK11) 
(Bridget Biersmith et al, 2011). 
Implicated in 
Breast cancer 
Expression of DOCK1 correlates with poor survival 
for HER2+ and basal breast cancer patients 
(Eckhardt et al., 2012; Perou et al., 2000). Dock1 
protein interacts with HER2 and enhances HER2-
induced Rac activation and cell migration (Laurin et 
al., 2013). 
Glioblastoma 
EGFR8, a constitutively active EGFR mutant, 
promotes glioma tumorigenesis and invasion 
through protein kinase A-dependent 
phosphorylation of DOCK1 (Feng H et al, 2014). 
Ovarian cancer 
Correlation of high Dock1 expression with poor 
survival for patients has been reported. Dock1 
overexpression contributes to enhanced ovarian 
cancer cell migration and invasion (Zhao F et al, 
2011). 
Lung cancer 
Dock1 can upregulate PTTG which could play a role 
in actin cytoskeleton remodeling, cell migration and 
induction of epithelial mesenchymal transition in 
lung cancer. The integrin alpha(V)beta(3)-FAK 
(focal adhesion kinase) signaling pathway is 
involved. (Shah PP et al, 2012). 
Gastric cancer 
Among genes involved in extracellular signal-
regulated kinase (ERK) downstream signaling 
pathways activated by Cytotoxin-associated antigen 
(CagA), a H. pylori immunoprotein, single 
nucleotide polymorphism of Dock1 was found to be 
significantly associated with risk of developing 
gastric cancer with marginal gene dose effects. 
(Yang JJ et al, 2011). 
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